{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T23:33:21Z","timestamp":1774222401639,"version":"3.50.1"},"reference-count":25,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>Intraventricular hemorrhage (IVH) is a major cause of neonatal morbidity and mortality in preterm infants without a specific medical treatment to date.<\/jats:p><\/jats:sec>Objective<\/jats:title>To assess the safety and short-term outcomes of high-dose erythropoietin in preterm infants with IVH.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>Between April 1, 2014, and August 3, 2018, a randomized double-blind clinical trial enrolled 121 preterm infants (gestational age &amp;lt;32 weeks or birth weight &amp;lt;1500 g) aged 8 or less days with moderate to severe IVH identified by cerebral ultrasonography from 8 Swiss and Austrian tertiary neonatal units. Statistical analyses were performed between October 1, 2019, and September 12, 2022.<\/jats:p><\/jats:sec>Interventions<\/jats:title>Infants received intravenous high-dose erythropoietin (2000 units\/kg body weight) or placebo at 4 time points between weeks 1 and 4 of life.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>Secondary outcomes included (1) mortality and morbidity rates and (2) brain magnetic resonance imaging findings at term-equivalent age (TEA). The primary outcome was the composite intelligence quotient at 5 years of age (not available before 2023).<\/jats:p><\/jats:sec>Results<\/jats:title>Sixty infants (48% male [n\u2009=\u200929]) were randomly assigned to receive erythropoietin, and 61 infants (61% male [n\u2009=\u200937]) were randomly assigned to receive placebo. The median birth weight was 832 g (IQR, 687-990 g) in the erythropoietin group and 870 g (IQR, 680-1110 g) in the placebo group. Median gestation was 26.1 weeks (IQR, 24.8-27.3 weeks) in the erythropoietin group and 27.0 weeks (24.9\u201328.1 weeks) in the placebo group. The 2 groups had similar baseline characteristics and morbidities. Up to TEA, 10 newborns died (16.7%) in the erythropoietin group, and 5 newborns (8.2%) died in the placebo group (adjusted odds ratio, 2.24 [95% CI, 0.74-7.66]; P<\/jats:italic>\u2009=\u2009.15). Infants receiving erythropoietin had higher mean hematocrit levels. Conventional magnetic resonance imaging at TEA for 100 infants showed no significant differences in global or regional brain injury scores.<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>This preliminary report of a randomized clinical trial found no evidence that high-dose erythropoietin in preterm infants with IVH affects brain injury scores on conventional magnetic resonance imaging at TEA. Higher mortality in the erythropoietin group was not significant but should be reassessed based on future results from similar trials.<\/jats:p><\/jats:sec>Trial Registration<\/jats:title>ClinicalTrials.gov Identifier: NCT02076373<\/jats:ext-link><\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2022.44744","type":"journal-article","created":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T11:31:09Z","timestamp":1669980669000},"page":"e2244744","source":"Crossref","is-referenced-by-count":15,"title":["Safety and Short-term Outcomes of High-Dose Erythropoietin in Preterm Infants With Intraventricular Hemorrhage"],"prefix":"10.1001","volume":"5","author":[{"given":"Sven","family":"Wellmann","sequence":"first","affiliation":[{"name":"Department of Neonatology, University Children\u2019s Hospital Regensburg, Hospital St Hedwig of the Order of St John, University of Regensburg, Regensburg, Germany"},{"name":"Division of Neonatology, University Children\u2019s Hospital Basel, University of Basel, Basel, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelia F.","family":"Hagmann","sequence":"additional","affiliation":[{"name":"Department of Neonatology and Pediatric Intensive Care, University Children\u2019s Hospital Zurich, Zurich, Switzerland"},{"name":"Children\u2019s Research Center, University Children\u2019s Hospital Zurich, Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanie","family":"von Felten","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Institute of Epidemiology, Biostatistics and Prevention, University of Zurich, Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonard","family":"Held","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Institute of Epidemiology, Biostatistics and Prevention, University of Zurich, Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrin","family":"Klebermass-Schrehof","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Adolescent Medicine, Medical University Vienna, Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita C.","family":"Truttmann","sequence":"additional","affiliation":[{"name":"Clinic of Neonatology, Department of Women Mother Child, University Center Hospital and University of Lausanne, Vaud, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Kn\u00f6pfli","sequence":"additional","affiliation":[{"name":"Newborn Research, Department of Neonatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Claude","family":"Fauch\u00e8re","sequence":"additional","affiliation":[{"name":"Newborn Research, Department of Neonatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"B\u00fchrer","sequence":"additional","affiliation":[{"name":"Department of Neonatology, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans Ulrich","family":"Bucher","sequence":"additional","affiliation":[{"name":"Newborn Research, Department of Neonatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph M.","family":"R\u00fcegger","sequence":"additional","affiliation":[{"name":"Newborn Research, Department of Neonatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Erythropoietin for the Repair of Cerebral Injury in Very Preterm Infants (EpoRepair) Investigators","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Meyer","sequence":"additional","affiliation":[{"name":"for the Erythropoietin for the Repair of Cerebral Injury in Very Preterm Infants (EpoRepair) Investigators"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Konetzny","sequence":"additional","affiliation":[{"name":"for the Erythropoietin for the Repair of Cerebral Injury in Very Preterm Infants (EpoRepair) Investigators"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corinne","family":"D\u00e4ster","sequence":"additional","affiliation":[{"name":"for the Erythropoietin for the Repair of Cerebral Injury in Very Preterm Infants (EpoRepair) Investigators"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sven M","family":"Schulzke","sequence":"additional","affiliation":[{"name":"for the Erythropoietin for the Repair of Cerebral Injury in Very Preterm Infants (EpoRepair) Investigators"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Severin","family":"Kasser","sequence":"additional","affiliation":[{"name":"for the Erythropoietin for the Repair of Cerebral Injury in Very Preterm Infants (EpoRepair) Investigators"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Gerull","sequence":"additional","affiliation":[{"name":"for the Erythropoietin for the Repair of Cerebral Injury in Very Preterm Infants (EpoRepair) Investigators"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathias","family":"Nelle","sequence":"additional","affiliation":[{"name":"for the Erythropoietin for the Repair of Cerebral Injury in Very Preterm Infants (EpoRepair) Investigators"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benedikt","family":"Bubl","sequence":"additional","affiliation":[{"name":"for the Erythropoietin for the Repair of Cerebral Injury in Very Preterm Infants (EpoRepair) Investigators"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"B\u00e4r","sequence":"additional","affiliation":[{"name":"for the Erythropoietin for the Repair of Cerebral Injury in Very Preterm Infants (EpoRepair) Investigators"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigitte","family":"Scharrer","sequence":"additional","affiliation":[{"name":"for the Erythropoietin for the Repair of Cerebral Injury in Very Preterm Infants (EpoRepair) Investigators"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Riedel","sequence":"additional","affiliation":[{"name":"for the Erythropoietin for the Repair of Cerebral Injury in Very Preterm Infants (EpoRepair) Investigators"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Fran\u00e7ois","family":"Tolsa","sequence":"additional","affiliation":[{"name":"for the Erythropoietin for the Repair of Cerebral Injury in Very Preterm Infants (EpoRepair) Investigators"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bjarte","family":"Rogdo","sequence":"additional","affiliation":[{"name":"for the Erythropoietin for the Repair of Cerebral Injury in Very Preterm Infants (EpoRepair) Investigators"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Hoigne","sequence":"additional","affiliation":[{"name":"for the Erythropoietin for the Repair of Cerebral Injury in Very Preterm Infants (EpoRepair) Investigators"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9","family":"Birkenmaier","sequence":"additional","affiliation":[{"name":"for the Erythropoietin for the Repair of Cerebral Injury in Very Preterm Infants (EpoRepair) Investigators"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giancarlo","family":"Natalucci","sequence":"additional","affiliation":[{"name":"for the Erythropoietin for the Repair of Cerebral Injury in Very Preterm Infants (EpoRepair) Investigators"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelika","family":"Berger","sequence":"additional","affiliation":[{"name":"for the Erythropoietin for the Repair of Cerebral Injury in Very Preterm Infants (EpoRepair) Investigators"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Thajer","sequence":"additional","affiliation":[{"name":"for the Erythropoietin for the Repair of Cerebral Injury in Very Preterm Infants (EpoRepair) Investigators"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","published-online":{"date-parts":[[2022,12,2]]},"reference":[{"issue":"10","key":"zoi221266r1","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1001\/jama.2015.10244","article-title":"Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993-2012.","volume":"314","author":"Stoll","year":"2015","journal-title":"JAMA"},{"issue":"6","key":"zoi221266r2","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1542\/peds.2015-0944","article-title":"Periventricular\/intraventricular hemorrhage and neurodevelopmental outcomes: a meta-analysis.","volume":"136","author":"Mukerji","year":"2015","journal-title":"Pediatrics"},{"issue":"1","key":"zoi221266r3","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/S1474-4422(08)70294-1","article-title":"Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances.","volume":"8","author":"Volpe","year":"2009","journal-title":"Lancet Neurol"},{"issue":"11","key":"zoi221266r4","doi-asserted-by":"publisher","first-page":"e636","DOI":"10.1542\/neo.20-11-e636","article-title":"Intraventricular hemorrhage and white matter injury in preclinical and clinical studies.","volume":"20","author":"Romantsik","year":"2019","journal-title":"Neoreviews"},{"issue":"5","key":"zoi221266r5","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1002\/ana.21977","article-title":"Erythropoietin improves neurodevelopmental outcome of extremely preterm infants.","volume":"67","author":"Neubauer","year":"2010","journal-title":"Ann Neurol"},{"key":"zoi221266r6","doi-asserted-by":"publisher","first-page":"486","DOI":"10.2119\/molmed.2011.00414","article-title":"The receptor that tames the innate immune response.","volume":"18","author":"Brines","year":"2012","journal-title":"Mol Med"},{"key":"zoi221266r7","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.657228","article-title":"Prophylactic erythropoietin for neuroprotection in very preterm infants: a meta-analysis update.","volume":"9","author":"Fischer","year":"2021","journal-title":"Front Pediatr"},{"key":"zoi221266r8","doi-asserted-by":"publisher","DOI":"10.1002\/14651858","article-title":"Early erythropoiesis-stimulating agents in preterm or low birth weight infants.","volume":"2","author":"Ohlsson","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"zoi221266r9","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1159\/000437248","article-title":"Erythropoietin for the Repair of Cerebral Injury in Very Preterm Infants (EpoRepair).","volume":"108","author":"R\u00fcegger","year":"2015","journal-title":"Neonatology"},{"issue":"4","key":"zoi221266r10","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S0022-3476(78)80282-0","article-title":"Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm.","volume":"92","author":"Papile","year":"1978","journal-title":"J Pediatr"},{"issue":"9","key":"zoi221266r11","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1111\/j.1469-8749.2011.04024.x","article-title":"The role of birthweight discordance in the intellectual and motor outcome for triplets at early school age.","volume":"53","author":"Natalucci","year":"2011","journal-title":"Dev Med Child Neurol"},{"issue":"7","key":"zoi221266r12","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1056\/NEJMoa053792","article-title":"Neonatal MRI to predict neurodevelopmental outcomes in preterm infants.","volume":"355","author":"Woodward","year":"2006","journal-title":"N Engl J Med"},{"issue":"8","key":"zoi221266r13","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1001\/jama.2014.9645","article-title":"Association between early administration of high-dose erythropoietin in preterm infants and brain MRI abnormality at term-equivalent age.","volume":"312","author":"Leuchter","year":"2014","journal-title":"JAMA"},{"issue":"2","key":"zoi221266r14","doi-asserted-by":"publisher","first-page":"e444","DOI":"10.1542\/peds.2013-2336","article-title":"Brain injury and altered brain growth in preterm infants: predictors and prognosis.","volume":"134","author":"Kidokoro","year":"2014","journal-title":"Pediatrics"},{"issue":"6","key":"zoi221266r15","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/sj.jp.7210963","article-title":"Safety, reliability, and validity of a physiologic definition of bronchopulmonary dysplasia.","volume":"23","author":"Walsh","year":"2003","journal-title":"J Perinatol"},{"issue":"1","key":"zoi221266r17","doi-asserted-by":"publisher","DOI":"10.2196\/16204","article-title":"PediTools electronic growth chart calculators: applications in clinical care, research, and quality improvement.","volume":"22","author":"Chou","year":"2020","journal-title":"J Med Internet Res"},{"key":"zoi221266r18","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/1471-2431-13-59","article-title":"A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants.","volume":"13","author":"Fenton","year":"2013","journal-title":"BMC Pediatr"},{"key":"zoi221266r19","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/1471-2288-11-144","article-title":"How to handle mortality when investigating length of hospital stay and time to clinical stability.","volume":"11","author":"Brock","year":"2011","journal-title":"BMC Med Res Methodol"},{"issue":"10","key":"zoi221266r20","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.3390\/brainsci11101360","article-title":"Diffusion tensor imaging changes do not affect long-term neurodevelopment following early erythropoietin among extremely preterm infants in the Preterm Erythropoietin Neuroprotection Trial.","volume":"11","author":"Law","year":"2021","journal-title":"Brain Sci"},{"key":"zoi221266r21","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jpeds.2021.08.040","article-title":"Association between term equivalent brain magnetic resonance imaging and 2-year outcomes in extremely preterm infants: a report from the Preterm Erythropoietin Neuroprotection Trial cohort.","volume":"239","author":"Mayock","year":"2021","journal-title":"J Pediatr"},{"key":"zoi221266r22","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004868.pub6","article-title":"Late erythropoiesis-stimulating agents to prevent red blood cell transfusion in preterm or low birth weight infants.","volume":"1","author":"Aher","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"zoi221266r23","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/ana.v80.1","article-title":"Recombinant human erythropoietin improves neurological outcomes in very preterm infants.","volume":"80","author":"Song","year":"2016","journal-title":"Ann Neurol"},{"issue":"3","key":"zoi221266r24","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1056\/NEJMoa1907423","article-title":"A randomized trial of erythropoietin for neuroprotection in preterm infants.","volume":"382","author":"Juul","year":"2020","journal-title":"N Engl J Med"},{"key":"zoi221266r25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2015.02.052","author":"Fauch\u00e8re","year":"2015","journal-title":"J Pediatr"},{"key":"zoi221266r16","unstructured":"R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing; 2020. Accessed October 24, 2022. https:\/\/www.r-project.org\/"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2799123\/wellmann_2022_oi_221266_1669144533.61378.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T11:31:15Z","timestamp":1669980675000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2799123"}},"subtitle":["The EpoRepair Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2022,12,2]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.44744","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,2]]}}}